Tolerance of benznidazole in a United States Chagas Disease clinic.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 25601454.
- Also identified by DOI 10.1093/cid/civ005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The US-based Center of Excellence for Chagas Disease performed an observational study on the safety and tolerance of benznidazole 5 mg/kg/day for 60 days in 30 adults with chronic Chagas disease. The side-effect profile was suboptimal, including 5 cases of debilitating neuropathy and an unusually high angioedema rate.
Medical subject headings
- Chagas Disease
- Drug-Related Side Effects and Adverse Reactions
- Nitroimidazoles
- Trypanocidal Agents